ASCP-SIG

These webinars are organised by the APSAD Smoking Cessation Professionals (ASCP) Special Interest Group for APSAD members, providing the opportunity to share information and knowledge through regular contact and webinars. The aim is the promotion of optimal smoking cessation practice in Australasia by trained health professionals incorporating evidence-based practice with an ongoing learning objective.

Membership of the ASCP-SIG is open to APSAD members with an interest in Smoking Cessation. For information contact the APSAD at This email address is being protected from spambots. You need JavaScript enabled to view it.

Save the date upcoming webinar.

TUESDAY 30 May at 12 PM (AEST)
The patient experience of adults with Chronic Obstructive Pulmonary Disease (COPD) in Australian general practice
Presenter: Sanduni Madawala, Research Fellow/Research Assistant, Department of General Practice, Monash University

Registration Terms and Conditions

Any persons affiliated with tobacco entities (current, in the past, or have future plans), tobacco lobbyists, either professionally or on a personal basis, will be ineligible to attend or present at any APSAD webinar or event.

APSAD’s policy is aligned with the World Health Organization’s Framework Convention on Tobacco Control, Article 5.3: There is a fundamental and irreconcilable conflict between the tobacco industry’s interest and public health policy interests.

Registrations from such persons will be cancelled without notice. Paid registrations of such persons will not be refunded.

The views expressed by presenters and speakers are not necessarily the views of APSAD, and the Society does not accept responsibility for any information, research, recommendation or advice presented.

-----------------------------------------------------------------------------------------------

Catch up on the past ASCP webinars

Previous Recordings

April 2023 | Why has Australia failed to implement tobacco endgame policies and what might precipitate policy adoption?

Modelling indicates that tobacco endgame policies will rapidly reduce smoking and improve health equity. Andrew’s PhD study uses applied policy research to explore themes and framing of tobacco endgame policies for Australia. Approaches include comparative policy analysis, and analysis of media articles, public health submissions and interviews with policy stakeholders. Dominant public health models and theories of the policy process inform the research designs and data analysis.

Presenter: Andrew Perusco PhD Student/ Sir Roland Wilson Scholar Team/Department National Centre for Aboriginal and Torres Strait Islander Wellbeing Research/ NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame

WATCH THIS WEBINAR

March 2023 | High-dose transdermal nicotine replacement therapy: Risk of overdose or best practice?

Nicotine Replacement Therapy (NRT) has been an approved first-line smoking cessation therapy for almost 40 years. When used in recommended doses, NRT increases the odds of a person quitting smoking. However, smokers range in nicotine plasma levels and some smokers are more highly dependent than others. So for a high nicotine dependent smoker, the recommended doses may be insufficient to manage withdrawals and “ replace” the nicotine.This presentation explores the evidence around using multiple patches concurrently, and provides some practical case studies illustrating how it can be approached.

Presenters: Prof Renee Bittoun Tobacco Treatment Specialist, Consultant, Professor, Nicotine Addiction Unit, Lifestyle Medicine, Avondale University, Australia, and the Medical School, University of Notre Dame, Australia and Andrew Mark Health Promotion Officer, Illawarra Shoalhaven Local Health District

WATCH THIS WEBINAR

February 2023 | The cardiovascular risk & benefits of smoking cessation pharmacotherapies use among cardiac patients

This webinar reports the results of three population-based cohort studies. The first provides evidence on how the three smoking cessation pharmacotherapies available in Australia (NRT, varenicline and bupropion) compare to each other in terms of cardiovascular safety. The second describes the use of these pharmacotherapies among patients who hospitalised in NSW with major cardiovascular disease. Our third study compares the effectiveness of NRT and varenicline in preventing recurrent cardiovascular events.

Presenters: Dr Alys Havard a Senior Research Fellow based at the National Drug and Alcohol Research Centre and the School of Population Health, UNSW Sydney and Dr Annelies Robijn a Postdoctoral Research Fellow based at the National Drug and Alcohol Research Centre UNSW Sydney. Presentation Slides

WATCH THIS WEBINAR

January 2023 | Smoking Cessation for Hospitalised Patients - Do We Have Time to Intervene?

In the first ASCP webinar of 2023 Associate Professor Ben Kwan will review the concept of hospital based smoking intervention, different approaches and model of care. Along with the role of different health professional groups within the acute care setting to aid in smoking cessation.

Presenter A/Prof Benjamin Kwan: Senior Staff Specialist, St Vincent's Hospital, Sydney & Sutherland Hospital

WATCH THIS WEBINAR

ASCP-SIG

Quick Links